quantisnow
FeedTopReportsPricing
⌘K
Live feed
14:43:36·849d
NEWSRelease
AstraZeneca PLC logo
Gracell Biotechnologies Inc. logo
PARTS iD Inc. logo
+4

Nasdaq Surges 75 Points; Inspira Technologies Shares Spike Higher

AZN· AstraZeneca PLCGRCL· Gracell Biotechnologies Inc.ID· PARTS iD Inc.IINN· Inspira Technologies Oxy B.H.N. Ltd.KNW· Know Labs Inc.MIST· Milestone Pharmaceuticals Inc.
Health CareConsumer DiscretionaryIndustrials
Original source

Companies

  • AZN
    AstraZeneca PLC
    Health Care
  • GRCL
    Gracell Biotechnologies Inc.
    Health Care
  • ID
    PARTS iD Inc.
    Consumer Discretionary
  • IINN
    Inspira Technologies Oxy B.H.N. Ltd.
    Health Care
  • KNW
    Know Labs Inc.
    Industrials
  • MIST
    Milestone Pharmaceuticals Inc.
    Health Care
  • RYZB
    RayzeBio Inc.

Recent analyst ratings

  • Apr 10MISTUpdateRaymond James$6.00
  • Jan 27AZNUpdateCitigroup-
  • Dec 15MISTUpdateTD Cowen$8.00
  • Oct 27AZNUpdateJefferies-
  • Oct 16AZNUpdateDeutsche Bank-
  • Sep 11MISTUpdateWells Fargo$4.00

Related

  • INSIDER21h
    SEC Form 3 filed by new insider Rozanovich Yoav
  • SEC22h
    SEC Form 6-K filed by AstraZeneca PLC
  • SEC2d
    SEC Form 6-K filed by AstraZeneca PLC
  • INSIDER3d
    SEC Form 4 filed by Oliveto Joseph
  • SEC3d
    SEC Form 6-K filed by AstraZeneca PLC
  • PR3d
    Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD
  • PR7d
    Inspira Completes Commercial Deployment of its AME System at a Tier-1 U.S. Defense Entity
  • SEC7d
    SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022